One recent study demonstrates that narasin inhibits tumor metastasis and growth of ERα-positive breast cancer cells, and this is through inactivation of the TGF-β/SMAD3 and IL-6/STAT3 signaling pathways [11]. This evidence concerns the gene TGFB1 and breast carcinoma.